Patient-first. Collaborative. Data and insights-driven. Digitally underpinned.
These are the qualities of a healthcare system that actively serves its purpose – yet instead, the US is hindered by mounting financial toxicity, unprecedented politicization of science and eroding public trust.
After three years of extraordinary momentum, pharma is finally primed to lead healthcare’s reform. But to guarantee access for patients and deliver on the next generation of scientific innovation, we must first embody the traits that healthcare needs to thrive, and restructure in pursuit of change.
To seize the moment, every function needs to lead its own internal revolution. Patient testimony must be centered at every step of the value chain to become authentically patient-first. Early partnerships that propel scientific innovation and deepen value must be fostered between external and internal stakeholders alike. Data and insights capabilities need to be overhauled across Commercial, Medical and Evidence workstreams to deliver groundbreaking opportunities for personalized customer journeys and real-time evidence integration. And to ensure all of that can happen, it’s critical we underpin our entire organization with next-generation digital excellence that secures competitive advantage.
Reuters Events: Pharma USA 2023 is the place you’ll drive this critical systemic change. It’s where North America’s visionary pharma changemakers, leading solution providers, patient experts, and industry heavyweights – from across Commercial, Marketing, Medical, Patient, Access, RWE and Cell & Gene Therapy – will catapult commercial excellence, guarantee equitable access to healthcare and accelerate cross-industry partnerships.
Backed by a brand you can trust, Pharma USA will deliver everything you need to commit to wholesale business transformation, ingrain patient-first strategies into the heart of pharma’s fabric and heed the long-awaited rebirth of America’s healthcare system.
